GRTX Insider Trading Activity and SEC Form 4 Filings
GRTX insider trading summary
Over the past 12 months, insiders at Galera Therapeutics, Inc. (GRTX) reported 1 sale worth $1K by 1 insider and no open-market purchases on SEC Form 4. Net insider selling was $1K.
Latest GRTX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 20, 2025 | Mel Sorensen | President and CEO | Sell | $1K (70,000 @ $0.02) |
| Dec 30, 2024 | Nancy T Chang | Insider | Buy | $500K (7,644,932 @ $0.07) |
| Aug 16, 2024 | Mel Sorensen | President and CEO | Sell | $5K (67,015 @ $0.07) |
| Feb 8, 2024 | Yair Schneid | 10% Owner | Buy | $26K (150,000 @ $0.17) |
| Feb 7, 2024 | Yair Schneid | 10% Owner | Buy | $4K (25,000 @ $0.17) |
| Feb 7, 2024 | Yair Schneid | 10% Owner | Buy | $26K (150,000 @ $0.17) |
| Feb 6, 2024 | Yair Schneid | 10% Owner | Buy | $5K (25,000 @ $0.20) |
| Feb 5, 2024 | Yair Schneid | 10% Owner | Buy | $18K (97,402 @ $0.18) |
| Jan 30, 2024 | Yair Schneid | 10% Owner | Buy | $61K (335,000 @ $0.18) |
| Jan 29, 2024 | Yair Schneid | 10% Owner | Buy | $27K (150,000 @ $0.18) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.